Cite
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses
MLA
Tongwu Zhang, et al. “Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.” Cell Reports, vol. 29, no. 3, Oct. 2019, pp. 573–88. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....28d5b0c1b10f4dcbbea49bae116d00b8&authtype=sso&custid=ns315887.
APA
Tongwu Zhang, Nicholas K. Hayward, Boris C. Bastian, Kevin M. Brown, Iwei Yeh, Meenhard Herlyn, A. Hunter Shain, Robert L. Judson, Céline Berquet, Thomas Botton, Eric Talevich, Vivek Mishra, Antoni Ribas, Alexander Gagnon, Robert Ballotti, & Stéphane Rocchi. (2019). Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses. Cell Reports, 29(3), 573–588.
Chicago
Tongwu Zhang, Nicholas K. Hayward, Boris C. Bastian, Kevin M. Brown, Iwei Yeh, Meenhard Herlyn, A. Hunter Shain, et al. 2019. “Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.” Cell Reports 29 (3): 573–88. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....28d5b0c1b10f4dcbbea49bae116d00b8&authtype=sso&custid=ns315887.